S&P 500 Futures
(0.74%) 5 120.00 points
Dow Jones Futures
(0.15%) 38 344 points
Nasdaq Futures
(0.98%) 17 740 points
Oil
(1.04%) $84.44
Gas
(-6.59%) $1.530
Gold
(0.54%) $2 355.20
Silver
(0.74%) $27.56
Platinum
(0.34%) $923.60
USD/EUR
(0.13%) $0.933
USD/NOK
(0.55%) $11.01
USD/GBP
(0.03%) $0.800
USD/RUB
(-0.23%) $91.96

Realtime updates for Race Oncology Ltd [RAC.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated26 Apr 2024 @ 02:10

1.55% $ 1.310

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 02:10):
Profile picture for Race Oncology Ltd

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial...

Stats
Today's Volume 55 650.00
Average Volume 146 418
Market Cap 217.29M
EPS $0 ( 2024-02-25 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -18.71
ATR14 $0.0130 (0.99%)

Race Oncology Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Race Oncology Ltd Financials

Annual 2023
Revenue: $3.13M
Gross Profit: $2.85M (91.03 %)
EPS: $-0.0617
FY 2023
Revenue: $3.13M
Gross Profit: $2.85M (91.03 %)
EPS: $-0.0617
FY 2022
Revenue: $707 807
Gross Profit: $426 611 (60.27 %)
EPS: $-0.0731
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0794

Financial Reports:

No articles found.

Race Oncology Ltd

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators